
GSK vs NVS
$GSK vs $NVS head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GSK vs NVS: the quick read
- ·NVS is the larger company by market cap ($291.20B vs $94.14B).
- ·GSK has been more active on our scanner (62 vs 24 alerts in 30 days).
- ·NVS has the smaller float (1.91B vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 62 and 24 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·Both pay a dividend, so this is one of the few pairs here where yield is a fair tiebreaker.
- ·GSK is the one in play today, trading about 2.2x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GSK and NVS on TheDesperateTrader.
- Is GSK or NVS the better stock?
- "Better" depends on your goal, and these two are not alike. NVS is the larger company by market cap ($291.20B vs $94.14B). GSK has been more active on our scanner (62 vs 24 alerts in 30 days). NVS has the smaller float (1.91B vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GSK and NVS?
- The differences that matter: NVS is roughly 3x the size of the other by market cap ($94.14B vs $291.20B); they trade at very different share prices ($46.51 vs $143.11); GSK sits at 19% of its 52-week range against 44% for NVS; our scanner flagged GSK 62 times in the last 30 days against 24 for NVS. Everything above is measured from the latest completed session and SEC filings.
- Which of GSK and NVS is more active right now?
- Right now GSK is at about 2.2x its normal volume and NVS is at about 0.7x, so GSK is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GSK or NVS? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.